Capital World Investors Portfolio holdings
Capital World Investors (CWI), a division of Capital Group, one of the oldest and largest investment management firms in the world, was established in 1931 and is headquartered in Los Angeles, California. Specializing in active investment management, CWI focuses on long-term growth through a research-intensive approach, managing hundreds of billions in assets primarily through equity-focused mutual funds and institutional portfolios. It serves a diverse client base, including individual investors, financial advisors, and institutions, and is known for its flagship funds like the American Funds, which emphasize fundamental analysis and a multiple-portfolio-manager system to mitigate risk. With a global reach and a reputation for disciplined, value-oriented investing, CWI remains a cornerstone of Capital Group’s mission to deliver consistent, superior returns.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.92B |
| 3 |
JPMorgan Chase
JPM
|
+$1.37B |
| 4 |
Comcast
CMCSA
|
+$1.3B |
| 5 |
Microsoft
MSFT
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.5B |
| 2 |
Citigroup
C
|
+$1.43B |
| 3 |
Home Depot
HD
|
+$1.25B |
| 4 |
Gilead Sciences
GILD
|
+$1.21B |
| 5 |
PepsiCo
PEP
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.32% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 12.74% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Technology | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Novartis
NVS
$294B
| $79.4M | 0.02% |
1,042,344
| – | – |
|
302
Trimble
TRMB
$13.7B
| $77.7M | 0.02% |
+2,000,000
| New | +$72M |
|
303
BioMarin Pharmaceuticals
BMRN
$13.3B
| $76.4M | 0.02% |
1,120,000
-350,000
| -24% | -$25.8M |
|
304
IDEX
IEX
$17.5B
| $75.9M | 0.02% |
1,040,700
-260,000
| -20% | -$18.9M |
|
|
DBD
305
DELISTED
Diebold Nixdorf Incorporated
DBD
| $74.6M | 0.02% |
+1,869,328
| New | +$67.3M |
|
|
RWT
306
Redwood Trust
RWT
$588M
| $72.8M | 0.02% |
3,589,888
| – | – |
|
307
Progressive
PGR
$123B
| $71.4M | 0.02% |
2,950,000
-3,130,000
| -51% | -$76M |
|
308
Northwest Bancshares
NWBI
$2.29B
| $70.8M | 0.02% |
4,850,000
| – | – |
|
|
HSP
309
DELISTED
HOSPIRA INC
HSP
| $69.2M | 0.02% |
+1,600,000
| New | +$68.6M |
|
|
GMCR
310
DELISTED
KEURIG GREEN MTN INC
GMCR
| $68.6M | 0.02% |
+650,000
| New | +$64.5M |
|
311
Murphy USA
MUSA
$9.89B
| $68.5M | 0.02% |
1,688,000
-685,000
| -29% | -$27.7M |
|
312
BHP
BHP
$229B
| $67.8M | 0.02% |
+1,182,655
| New | +$66.3M |
|
313
Diamondback Energy
FANG
$56.5B
| $66.1M | 0.02% |
982,000
+82,000
| +9% | +$4.72M |
|
|
NBIS
314
Nebius Group N.V.
NBIS
$49.1B
| $66.1M | 0.02% |
2,188,600
+583,000
| +36% | +$21.5M |
|
315
Adobe
ADBE
$102B
| $65.7M | 0.02% |
+1,000,000
| New | +$64.1M |
|
|
GHL
316
DELISTED
Greenhill & Co., Inc.
GHL
| $65.7M | 0.02% |
1,263,500
| – | – |
|
317
AstraZeneca
AZN
$246B
| $65.5M | 0.02% |
1,010,000
-660,000
| -40% | -$42.6M |
|
|
GTLS
318
DELISTED
Chart Industries
GTLS
| $64.6M | 0.02% |
811,669
-93,500
| -10% | -$8.05M |
|
319
IQVIA
IQV
$39.5B
| $60.9M | 0.02% |
+1,200,000
| New | +$60.5M |
|
|
MCRS
320
DELISTED
MICROS SYSTEMS INC
MCRS
| $60.8M | 0.02% |
1,149,000
-86,000
| -7% | -$4.77M |
|
321
T. Rowe Price
TROW
$24.3B
| $59.3M | 0.02% |
720,000
| – | – |
|
322
Mativ Holdings
MATV
$706M
| $59M | 0.02% |
1,385,618
-1,029,400
| -43% | -$47M |
|
|
XOOM
323
DELISTED
XOOM CORP COM
XOOM
| $58.8M | 0.02% |
+3,013,000
| New | +$77.4M |
|
324
Oracle
ORCL
$419B
| $58.3M | 0.02% |
1,425,000
| – | – |
|
325
Alnylam Pharmaceuticals
ALNY
$29.3B
| $58.1M | 0.02% |
864,700
-190,000
| -18% | -$14.7M |
|
Similar funds
Capital World Investors's Q1 2014 Portfolio in Review
As of Q1 2014, Capital World Investors held 531 positions worth $351B, down 1.4% from $356B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Capital World Investors's Q1 2014 filing shows 47 new, 142 increased, 151 reduced and 30 closed positions. Its largest new stake was Veren: 13,907,139 shares worth $464M. The largest sale was Bristol-Myers Squibb, an estimated $1.5B.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- Capital World Investors's largest Q1 2014 buy was Veren: 13,907,139 shares worth $464M.
- Capital World Investors added most to Cisco in Q1 2014, an estimated $2.31B increase.
- Capital World Investors's biggest Q1 2014 reduction was Bristol-Myers Squibb, cutting an estimated $1.5B.
- Capital World Investors fully exited Coterra Energy in Q1 2014, selling an estimated $519M.
- Capital World Investors's ten largest holdings make up 24% of its $351B portfolio in Q1 2014.
- Capital World Investors opened 47 new positions and closed 30 in Q1 2014.
- Capital World Investors's portfolio value fell 1.4% quarter-over-quarter to $351B.
Based on Capital World Investors's 13F filing for Q1 2014, filed 15 May 2014.